Shire Pharmaceuticals was a global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. It has since been acquired by Takeda Pharmaceuticals, a patient-focused, R&D-driven global biopharmaceutical company.
Focus Areas
Notable Investments
